Page 12 - Chumakov News Today

Ссылка на регистрацию на участие в розыгрыше квартиры среди граждан, прошедших вакцинацию от коронавируса на территории Московской области, появилась на региональном портале госуслуг.

Заболеваемость коронавирусом растет из-за летних поездок россиян: Но привитые граждане переносят болезнь в легкой форме.

EpiVacCorona is a single-dose synthetic peptide vaccine against COVID-19 developed by the Vector State Research Center of Virology and Biotechnology

Minister assures Russia has sufficient vaccines for domestic use According to Russian Industry and Trade Minister Denis Manturov, in order to expand shipments to foreign markets, it is necessary to establish international partnerships with those countries, with which there are agreements on cooperation in this area © Gavriil Grigorov/TASS ST. PETERSBURG, June 3. /TASS/. Russia’s production capacity is currently sufficient to meet the domestic demand for coronavirus vaccines, Russian Indust...

Родственникам, которые живут вместе с пациентом с онкологическим заболеванием, обязательно следует привиться от коронавируса, чтобы снизить риск заражения... РИА Новости, 03.06.2021

Всего в регион доставили 3 120 доз вакцины "Ковивак"

Rest of World News: MOSCOW: Russia's third vaccine against Covid-19, CoviVac, is more than 80% effective according to preliminary data, the Interfax news agency cited the.

The Chumakov Centre could produce six times more than the previously planned 10 million doses of the vaccine a year

Developer says could produce six times more than previously planned 10 million doses a year

Russia's third vaccine against COVID-19, CoviVac, is more than 80% effective according to preliminary data, the Interfax news agency cited the vaccine's developer as saying on Wednesday.